Back to Treatments

Treatment

Trimethoprim-sulfamethoxazole (TMP-SMX)

1
Conditions
1
Trials
60K
Participants
70%
Average Safety

Condition Evidence

Urinary tract infections and interstitial nephritis

1 trials · 60K participants

88% effectiveness · 70% safety
Trimethoprim-sulfamethoxazole (TMP-SMX) | DFDA